While cannabis shows potential anti-inflammatory effects relevant to inflammatory bowel disease, the evidence in pediatric IBD is insufficient to support clinical use, with calls for more targeted research on safety and efficacy in children.
Parents of children with IBD, pediatric gastroenterologists, and anyone interested in cannabis for inflammatory conditions in children.
Pediatric IBD is rising, but cannabis cannot yet be recommended for children
What the researchers found
Cannabis may relieve IBD symptoms and improve quality of life in individual patients. The endocannabinoid system plays a role in gastrointestinal tract function with potential anti-inflammatory effects. However, no adequate pediatric evidence exists to recommend cannabis or cannabinoids for IBD in children.
Why it matters
Pediatric IBD is rising, and parents are increasingly asking about cannabis options. This review provides clinicians with a framework for discussing why cannabis cannot yet be recommended for children with IBD despite adult-oriented enthusiasm.
The numbers in context
Rising incidence of pediatric IBD onset. Current treatment relies on immunomodulatory therapy. Cannabis and purified ingredients show potential anti-inflammatory effects. No adequate pediatric safety or efficacy data exist.
How the study worked
Narrative review of recent literature on cannabis use in IBD with a focus on pediatric patients, including background on the endocannabinoid system in the gastrointestinal tract and discussion of various cannabis forms and purified ingredients.
What this study cannot tell us
Narrative review without systematic methodology. Limited primary research on cannabis in pediatric IBD. Draws mostly from adult data and extrapolation. Does not quantify the strength of anti-inflammatory effects.
How to read the evidence
Preliminary: narrative review acknowledging a fundamental lack of pediatric-specific evidence.
When this study was published
Published in 2019.
The bigger picture
The gap between adult interest in cannabis for IBD and pediatric evidence is particularly stark. Children metabolize drugs differently, have developing immune systems, and face different risk-benefit calculations than adults, making extrapolation from adult data inappropriate.
Questions still open
- What specific cannabinoids might be safest and most effective for pediatric IBD? Could topical or rectal administration minimize systemic exposure in children? What outcomes should pediatric clinical trials prioritize?
Common questions
Can cannabis help children with IBD?
Why can't we just use adult IBD data for children?
Read the original research
Cannabis, a potential treatment option in pediatric IBD? Still a long way to go.
Expert review of clinical pharmacology, 12(4), 355-361
Citation
Halbmeijer, Nienke; Groeneweg, Michael; De Ridder, Lissy. (2019). Cannabis, a potential treatment option in pediatric IBD? Still a long way to go.. Expert review of clinical pharmacology, 12(4), 355-361. https://doi.org/10.1080/17512433.2019.1582330
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk